Login to Your Account



Other News To Note


Monday, September 24, 2012
• Ironwood Pharmaceuticals Inc., of Cambridge, Mass., and Almirall SA, of Barcelona, Spain, said the European Committee for Medicinal Products for Human Use issued a positive opinion recommending the marketing approval for Constella (linaclotide) for the symptomatic treatment of moderate to severe irritable bowel syndrome with constipation in adults.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription